Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Obicetrapib 10 mg + ezetimibe 10 mg fdc daily's trials
REMBRANDT
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
Obicetrapib 10 mg + ezetimibe 10 mg FDC daily
Ongoing
Active not recruiting
Phase 3
Open NCT06305559 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
